Related Experiment Video
Updated: Nov 24, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Physical frailty in liver transplantation
Lorena Puchades Renau1, Julia Herreras López1, Maria Àngels Cebrià I Iranzo1
1Grupo de Hepatología y Trasplante Hepático, Instituto de Investigación Sanitaria La Fe, España.
Frailty in cirrhosis patients, especially liver transplant (LT) candidates, predicts poor outcomes. Standardizing frailty assessment is crucial for better clinical decisions and interventions.
Area of Science:
- Hepatology
- Geriatrics
- Transplantation Medicine
Background:
- Frailty is a significant issue in cirrhosis, particularly in liver transplant (LT) candidates.
- It is characterized by physical dysfunction, muscle wasting, and malnutrition.
- Frailty is linked to adverse outcomes before and after LT.
Purpose of the Study:
- To highlight the predictive value of frailty in LT candidates.
- To discuss the challenges in standardizing frailty assessment for LT.
- To emphasize the potential for frailty interventions.
Main Methods:
- Review of existing literature on frailty in cirrhosis and LT.
- Analysis of the impact of frailty on pre- and post-transplant outcomes.
- Discussion of heterogeneity in frailty measurement tools.
Main Results:
- Frailty is an independent predictor of adverse outcomes in LT candidates.
- Current methods for measuring frailty lack standardization across LT clinical settings.
- Data on the benefits of frailty improvement interventions are still emerging.
Conclusions:
- Incorporating frailty assessment into clinical practice can improve decision-making for LT candidates.
- Standardized frailty assessment tools are needed for equitable organ allocation.
- Further research is required to validate the impact of frailty interventions.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Kidney Transplant I: Introduction
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

